MedPath

TORAY INDUSTRIES, INC.

TORAY INDUSTRIES, INC. logo
🇹🇼Taiwan
Ownership
Public
Established
1926-04-16
Employees
48.1K
Market Cap
-
Website
http://www.toray.co.jp
Clinical Trials
Related News

Efficacy and Safety of TRK-700 in Patient With Post-Herpetic Neuralgia

Phase 2
Completed
Conditions
Post-Herpetic Neuralgia
Interventions
Drug: Placebo
First Posted Date
2016-03-08
Last Posted Date
2017-10-25
Lead Sponsor
Toray Industries, Inc
Target Recruit Count
184
Registration Number
NCT02701374
Locations
🇯🇵

Tokyo, Tokyo, Japan

TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

Phase 2
Completed
Conditions
Renal Insufficiency, Chronic
Interventions
Drug: Placebo
First Posted Date
2015-06-24
Last Posted Date
2015-06-29
Lead Sponsor
Toray Industries, Inc
Target Recruit Count
113
Registration Number
NCT02480751

Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis

First Posted Date
2012-08-08
Last Posted Date
2022-02-09
Lead Sponsor
Toray Industries, Inc
Target Recruit Count
45
Registration Number
NCT01660243

A Pharmacokinetic Study of TRK-100STP in Japanese Patients With Renal Impairment

Phase 1
Completed
Conditions
Renal Impairment
Interventions
First Posted Date
2011-09-29
Last Posted Date
2014-03-04
Lead Sponsor
Toray Industries, Inc
Target Recruit Count
24
Registration Number
NCT01443429
Locations
🇯🇵

Japan, Japan, Japan

A Study of TRK-170 for the Treatment of Crohn's Disease

Phase 2
Completed
Conditions
Crohn's Disease
Interventions
Drug: Placebo
First Posted Date
2011-05-02
Last Posted Date
2014-06-12
Lead Sponsor
Toray Industries, Inc
Target Recruit Count
123
Registration Number
NCT01345799
Locations
🇧🇬

Bulgaria, Bulgaria, Bulgaria

🇺🇦

Ukraine, Ukraine, Ukraine

🇸🇪

Sweden, Sweden, Sweden

and more 10 locations

TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

Phase 2
Completed
Conditions
Chronic Renal Failure
Glomerular Disease
Nephrosclerosis
Interventions
Drug: Placebo
Drug: TRK-100STP high dose
Drug: TRK-100STP low dose
First Posted Date
2010-03-19
Last Posted Date
2015-02-04
Lead Sponsor
Toray Industries, Inc
Target Recruit Count
892
Registration Number
NCT01090037

Phase II Study of TRK-820 Soft Capsules - Intractable Pruritus in Patients With Chronic Liver Disease -

Phase 2
Completed
Conditions
Pruritus With Chronic Liver Disease
Interventions
Drug: Placebo
First Posted Date
2008-03-19
Last Posted Date
2010-02-01
Lead Sponsor
Toray Industries, Inc
Target Recruit Count
120
Registration Number
NCT00638495
Locations
🇯🇵

Toray Industries, Inc, Urayasu, Chiba, Japan

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy